On May 2, 2023, NeuPath Health Inc. closed the transaction. The company has issued 1,453 units for gross proceeds of CAD 1,453,000 in the transaction. The debentures will mature on May 2, 2025 and bear interest at a rate of 10% per annum payable quarterly in arrears in cash.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.17 CAD | 0.00% | 0.00% | -8.11% |
03-15 | NeuPath Health Narrows Q4 Loss, Revenue Rises | MT |
03-15 | NeuPath Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.11% | 7.01M | |
-28.75% | 70.3B | |
+2.04% | 27.46B | |
-6.19% | 17.8B | |
+2.32% | 17.46B | |
+2.10% | 15.46B | |
+7.06% | 13.49B | |
+10.80% | 13.06B | |
+71.31% | 12.96B | |
+75.96% | 12.56B |
- Stock Market
- Equities
- NPTH Stock
- News NeuPath Health Inc.
- NeuPath Health Inc. announced that it has received CAD 1.453 million in funding